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Abstract 
Over the past years, spider silk has drawn considerable attention from researchers 
because of its renowned mechanical strength (force needed to break), elasticity, 
biocompatibility and biodegradability. The advancements in genetic engineering have 
led to the production of artificial mimics of spider silk proteins. 
The main objective of this thesis is to functionalize two variants of partial spider silk, 
4RepCT (RC), 23 kDa and NTCT (NC), 27 kDa, by covalent attachment to affinity 
domains at gene level. Retained functional properties of the silk part and added affinity 
domains were studied in the resulting silk fusion proteins.  
In Paper I, four affinity domains of different sizes (5-17 kDa) with different folds 
were genetically attached to the RC silk variant. We confirmed that all four RC silk 
fusion proteins could self-assemble to silk-like fibers. The ability of each added affinity 
domain to bind its respective target while in RC silk fusion protein was also confirmed. 
A non-covalent way of presenting biotinylated growth factors was achieved by one of 
the constructs; M4-4RepCT silk. In a similar way, presentation of an active enzyme 
was verified by the activity measurement of the silk-fusion material with bound 
enzyme. Thus, these findings highlight the use of such materials in for example cell 
culture and tissue engineering applications. 
In Paper II, as a proof-of-concept, two recombinant antibody fragments (scFvs) each 
of 30 kDa, previously shown to contribute to the candidate protein signature for 
diagnosing systemic lupus erythematosus (SLE), were covalently attached to either 
ends of RC and NC silk variants. All of the generated scFv-RC and scFv-NC silk 
fusion proteins were shown able to self-assemble to fibres. The retained functionalities 
of scFv domains in scFv-RC/NC silk fusion proteins were confirmed in micro- and 
nanoarrays, respectively. Significantly higher target detection signal was reported by 
scFv-silk fusion proteins when compared to the same added amount of scFvs alone in 
the immunoassays. Thereby, suggesting the use of scFv-silk fusion proteins as capture 
probes in generation of sensitive diagnostic immunoassays. 
The overall results from this thesis thus highlight the diverse possible applications of 
partial spider silk proteins after being functionalized with various affinity domains. 
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single chain variable fragments, functionalization. 
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1 Introduction 
The capability to generate silk, a natural protein fiber, has developed by 
spiders, several arthropods and 23 groups of insects (Walker et al., 2012; 
Sutherland et al., 2010; Altman et al., 2003). Due to the remarkable 
mechanical and elastic properties of the silk derived from spiders, combined 
with its biocompatibility, spider silk has been exploited for biomaterial and 
biomedical applications (Borkner et al., 2014; Bittencourt et al., 2012; Widhe 
et al., 2012; Omenetto & Kaplan, 2010). However, additional functionalization 
is needed for generation of more advanced materials, which otherwise does not 
exist in nature. Processing of silk from cocoons produced by silkworms require 
harsh processing steps involving for example, degumming in alkali solution 
followed by solubilization in organic solvents like hexafluoroisopropanol, 
which restrict their use in applications where additional functionalization is 
needed (Rockwood et al., 2011). The work described in this thesis is mainly 
based on the silk derived from spider silk, thus information regarding other 
kinds of silk is not described and can be found elsewhere (Kasoju & Bora, 
2012; Sutherland et al., 2010). 
1.1 Overview of spider silk 
1.1.1 Natural spider silk 
In nature, orb weaving spiders can generate up to seven types of silks, which 
have different physical properties and perform different functions (Rising et 
al., 2011). Out of the seven types of spider silks, dragline silk that is produced 
in the major ampullate gland of spider has widely been studied for its 
incredible mechanical properties (Borkner et al., 2014; An et al., 2012; 
Bittencourt et al., 2012). Spider dragline silk is composed of two high 
molecular weight proteins (Ayoub et al., 2007; Bini et al., 2006), namely 
Major ampullate spidroin 1 and 2 (MaSp1 and MaSp2, respectively) (Humenik 
et al., 2011). The dragline silk spidroins produced by various species of spiders 
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share a common tripartite protein architecture (Humenik et al., 2011). They are 
composed of a non-repetitive N-terminal domain, a repetitive region mainly 
containing poly-alanine segments interspersed between glycine rich repeats, 
and a non-repetitive C-terminal domain (Ayoub et al., 2007). The repetitive 
region, which is composed of different amino acid segments, was reported to 
account for the amazing physical properties of the dragline silk (Rising et al., 
2011).  Naturally, spiders produce silk in liquid form (dope) and store it at high 
concentrations (50% w/v) within specialized silk glands (Chen et al., 2002). 
Upon changes in the ion composition, pH, dehydration (Walker et al., 2012), 
and shear forces occurring along the duct (Dicko et al., 2004; Knight & 
Vollrath, 2001); stored silk solution will emerge out as silk fibers, which are 
rich in β-sheets (Gosline et al., 1999; Simmons et al., 1996). The 
intermolecular interactions occurring between the poly-alanine segments and 
glycine rich repeats in the repeat region (Rising et al., 2011), combined with 
the N-terminal (Askarieh et al., 2010) and C-terminal domain (Hagn et al., 
2010) of the spidroins were reported to regulate the process of silk fibre 
formation.  
The dragline silk of Euprosthenops is stronger than that from other species 
of spiders like Nephila, Araneus and Latrodectus (Stark et al., 2007; 
Pouchkina-Stantcheva & McQueen-Mason, 2004). Advantages and limitations 
in production of natural and engineered dragline silks are addressed in a later 
section.   
1.1.2 Recombinant production of partial spider silk in bacteria 
The predatory behaviour of spiders together with the insufficient amounts of 
silk produced by spiders, have restricted the option to perform sericulture of 
spiders and hence opted for recombinant production of spider silk proteins 
(Guhrs et al., 2000). Recombinant production is defined as the expression of a 
foreign gene in a production host, for example bacteria (Tokareva et al., 2013). 
Due to the well characterized genome and low costs involved in production, 
Escherichia coli (E.coli) is often considered as a suitable option for large scale 
protein production. 
Due to the repetitive nature and large size of natural spider silk genes in 
general, issues like premature translational stops, low protein yield and 
homologous recombination to host genome, can be of concern when expressed 
in the bacteria (Arcidiacono et al., 1998). For this reason, partial spider silk 
sequences are preferred for production of artificial spider silk mimics in 
bacteria (Tokareva et al., 2013; Stark et al., 2007; Prince et al., 1995). 
However, with recent progress in the field of genetic engineering together with 
the modular nature of spider silk, different partial spider silk proteins derived 
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from different species of spiders have been produced in various hosts including 
yeast, bacteria, insects, plants and mammalian cells with varying success 
(Tokareva et al., 2013; Rising et al., 2011). Some of the partial spider silks 
which were cloned and expressed in bacteria include repeat segments derived 
from MaSp1 and MaSp2 of Nephila clavipes with (Prince et al., 1995) or 
without (Mello et al., 2004) inclusion of a native C-terminal domain. Another 
example of partial spider silk is 4RepCT (RC silk), composed of four poly-
alanine/glycine rich co-segments together with a C-terminal domain derived 
from MaSp1 of Euprosthenops australis (E. australis) (Stark et al., 2007). 
Likewise, another partial spider silk variant, NTCT (NC silk) was herein 
generated by combining native N-terminal and C-terminal domains derived 
from E. australis. The study presented in this thesis is based on these two 
partial spider silk variants, RC and NC silks. 
Major steps involved in the recombinant production of partial spider silk 
proteins in bacteria are (Figure 1): (i) Isolation of full length spider silk cDNA 
from spider, (ii) Selection of cDNA that codes for partial spider silk protein, 
(iii) restriction cleavage of target vector, (iv) ligation of partial spider silk 
cDNA to the cleaved target vector, (v) transformation of generated 
recombinant DNA (rDNA) into bacteria, (vi) expression of rDNA in the 
bacteria, (vii) harvesting the purified partial spider silk proteins from the 
bacteria mainly using affinity purification (Stark et al., 2007; Prince et al., 
1995). All the steps are represented in Figure 1. 
 
 
Figure 1. Scheme of recombinant production of partial spider silk proteins in bacteria. 
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1.1.3 Processing of partial spider silk proteins to various formats 
The success of recombinant production in bacteria has enabled a convenient 
way to produce partial spider silk proteins under denaturing (Humenik et al., 
2011) and non-denaturing conditions (Stark et al., 2007). Moreover, the 
produced partial spider silk proteins have an advantage of being possible to 
process into unnatural silk morphologies like, foam, film and mesh formats 
with (Hardy & Scheibel, 2009) or without (Widhe et al., 2010) being subjected 
to post-treatment with organic solvents for β-sheet enrichment. Partial spider 
silk variants which are produced under non-denaturing conditions without any 
requirement of organic solvents during material fabrication might have better 
opportunities for modification with a wide range of biologically active 
molecules. 
1.1.4 Modification of partial spider silk proteins 
Chemical or genetic modification of partial spider silk proteins will broaden 
the applicability window of silk based materials (Wohlrab et al., 2012; Spieß et 
al., 2010). Chemical modification can be achieved by the use of established 
procedures that permit efficient and site-specific modifications of proteins 
(Hackenberger & Schwarzer, 2008). However, certain coupling chemicals used 
for modification of silk materials might exhibit side-effects that are detrimental 
to cells when used for tissue engineering applications (Wohlrab et al., 2012). In 
those cases, genetic modification of partial spider silk proteins could be used as 
a more beneficial alternative. The possibility to genetically modify partial 
spider silk has been shown by the addition of cell binding motifs using genetic 
engineering method with convincing results in cell culture studies (Widhe et 
al., 2016; Widhe et al., 2013; Wohlrab et al., 2012). 
1.2 Different ways to immobilize proteins onto solid supports 
Methods which rely on the binding of target molecules to complementary 
“bait” molecules depend on the immobilization of those bait molecules to a 
solid support. This section describes different ways to immobilize proteins, 
which constitute one important group of such bait molecules. For example, 
antibodies are immobilized to solid support for their use in affinity purification 
and immunoassays. 
Immobilization of proteins on solid surfaces is of great importance in the 
production of protein based arrays and biosensor related applications. The 
challenging task is to immobilize the proteins in such way their functionality 
and orientation are maintained, and also to remain their conformation unaltered 
after immobilization (Oshige et al., 2013). Furthermore, restricting the 
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interaction between the immobilized antibodies and the solid surface might 
help to achieve an appreciable portion of antibodies that retain their native 
confirmation. 
Addressing the above challenges can allow for the successful use of 
immobilized proteins for their intended applications. The chemical and 
structural complexity of proteins have created difficulties in determining a 
general strategy for immobilization of proteins (Saerens et al., 2008). Different 
ways to immobilize proteins on various surfaces have been reported, namely 1) 
non-covalent physical adsorption, 2) covalent coupling via free amines or thiol 
groups and 3) non-covalent protein linkage via affinity interactions (e.g., 
His6/Ni-NTA) (Oshige et al., 2013; Kimple et al., 2010). In all cases, physical 
and chemical properties of the surface and also other factors like temperature 
and pH have been shown to affect the surface immobilization of the proteins 
(Oshige et al., 2013).  
Non-specific physical adsorption is a quick way to immobilize protein 
molecules, but often leads to protein denaturation (Butler et al., 1993). In order 
to prevent the denaturation of immobilized proteins, they can be spotted onto 
solid surfaces, which have been pre-coated with e.g. polyacrylamide gels or 
polyethylene glycol (Pollak et al., 1980). In the covalent coupling method, 
reactive functional groups present in the protein molecules (e.g., amines, 
thiols) are crosslinked onto the solid support modified with complementary 
reactive groups, thus ensuring protein immobilization (Oshige et al., 2013; 
Camarero, 2008). However, the immobilization methods described above does 
often not result in well oriented protein molecules, which is necessary for 
efficient binding of their target molecules (Oshige et al., 2013; Camarero, 
2008). The orientation of immobilized protein molecules can be improved by 
use of a non-covalent protein immobilization via affinity. For example, 
proteins carrying histidine tags can be immobilized onto solid surface which is 
coated with Ni-NTA molecules. However, use of non-covalent means of 
immobilization is limited by the lack of long-term stability of the immobilized 
proteins (Camarero, 2008). 
1.3 Affinity domains 
One important class of proteins that is beneficial to have immobilized onto 
surfaces for certain applications are affinity domains. 
1.3.1 Domains derived from bacterial surface receptors 
In the recent past, exploiting the host defense mechanisms developed by 
bacteria for their use in the field of biotechnology has gained considerable 
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attention (Diamandis & Christopoulos, 1991). Bacterial strains of the 
Staphylococci, Streptococci and Streptomyces genera express certain proteins 
in order to evade the host immune system (Sauer-Eriksson et al., 1995; 
Diamandis & Christopoulos, 1991). Out of the several IgG-binding bacterial 
proteins that were identified, staphylococcal protein A (SPA) and streptococcal 
protein G (SPG) are extensively studied for their use in the purification of 
antibodies (Boström et al., 2012). 
SPA contains five homologous IgG-binding domains. The Z domain (7 
kDa), which folds into a three-helix bundle, is an engineered protein domain 
derived from the IgG-binding B-domain of SPA (58 kDa) (Boström et al., 
2012; Nilsson et al., 1987). SPG has a multi domain structure containing both 
albumin-binding domains and immunoglobulin-binding domains (Kraulis et 
al., 1996). The C2 domain (6 kDa), which folds into four β-sheets and α-helix 
structure is derived from the Fc binding domain B1 of SPG (Sauer-Eriksson et 
al., 1995). Both Z and C2 domains can be used for the purification of 
antibodies or target proteins fused to the Fc domain. SPA and SPG exhibit 
different specificities to IgG obtained from different species (Boström et al., 
2012). Likewise, species specific IgG binding of the domains derived from 
SPA and SPG can be speculated.  
The ABD domain is an engineered protein domain derived from albumin-
binding domain 3 of SPG (63 kDa). Domain ABD (5 kDa) has affinity towards 
human serum albumin and folds into a three-helix bundle (Nilvebrant & Hober, 
2013; Kraulis et al., 1996). 
1.3.2 Domain derived from streptavidin 
Streptavidin is a protein produced by Streptomyces avidinii, which has affinity 
towards biotin and biotinylated ligands (Diamandis & Christopoulos, 1991). 
The extreme affinity between biotin and streptavidin (Diamandis & 
Christopoulos, 1991) complicate the release of biotinylated ligands (Rybak et 
al., 2004). This resulted in the generation of monomeric streptavidin (M4) (Wu 
& Wong, 2005), which exhibit a lower binding affinity than streptavidin, in 
order to expand the applicability of biotin/streptavidin system for several 
biotechnological applications. M4 is a 16.5 kDa monomeric version of 
streptavidin, which has affinity to biotin molecules and folds into a β-sheet 
barrel structure (Wu & Wong, 2005). 
1.3.3 Domains derived from antibodies 
Naturally, antibodies are produced by B-cells in order to protect against foreign 
substances. As represented in Figure 2, antibodies are composed of two heavy 
and two light chains joined together by disulfide bonds. There are three 
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constant domains and one variable domain in the heavy chains, while there is 
one constant domain and one variable domain in the light chains (Figure 2). 
The epitope recognition site of an antibody is in the variable heavy (VH) and 
variable light (VL) domains. Due to excellent target specificity and affinity, 
antibodies are considered as paradigm for cell biology and biochemistry 
applications (Gebauer & Skerra, 2009). However, structural complexity and 
laborious procedures involved in the production of antibodies have led to 
creation of recombinant antibody fragments such as scFv and Fab (Gebauer & 
Skerra, 2009) (Figure 2). Considerable loss of biological activity has been 
observed upon immobilization of antibodies onto solid supports, which affects 
the sensitivity of the antibody based immunoassays, for example. Furthermore, 
the presence of the Fc part of the antibody can result in unwanted cell 
reactivity upon binding to the effector cells containing Fc receptors (Holliger & 
Hudson, 2005). 
Generation of antibody mimics was considered as a breakthrough in the 
field of antibody engineering. Monovalent Fabs (55 kDa) are generated from 
full-length antibodies subjected to papain cleavage (Porter, 1959), whereas, 
single-chain variable fragment, scFv (28 kDa), one of the most popular formats 
of antibody derivatives, is generated by the fusion of variable domains of the 
heavy and light chain (VH and VL) joined by a flexible linker. Generated Fab 
and scFv fragments are smaller in size when compared to the antibodies 
(Figure 2) and can be expressed in E. coli with retained antigen binding affinity 
of the intact IgG (Bird et al., 1988). Due to the smaller size of scFv and due to 
less efficient folding and assembly of Fab fragments in E. coli (Hust et al., 
2007), scFv is considered as a suitable affinity ligand for different applications, 
immunoassays for example. The biomolecular properties, like stability, can be 
enhanced by engineering scFvs (Worn & Pluckthun, 2001).  
 
Figure 2. Representation of an antibody and domains derived from an antibody. 
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1.4 Diverse applications of functionalized partial spider silk 
The relevance of functionalized partial spider silk for diverse applications is an 
actively growing field of research. Partial spider silk proteins, which can be 
produced using recombinant DNA technology can be subjected to genetic 
modifications by incorporation of peptides, recognition motifs or functional 
domains (Borkner et al., 2014). In the recent past, cell binding peptides have 
successfully been incorporated to different engineered spider silk proteins, 
thereby suggesting the applicability of such functional silk materials for in 
vitro cell culture studies (Widhe et al., 2013; Wohlrab et al., 2012). 
Furthermore, silver binding peptides (Currie et al., 2011) and antimicrobial 
peptides (Gomes et al., 2011) were genetically incorporated to partial spider 
silk and the added peptides were reported to retain their functionalities, thus 
highlighting the use of silk-silver and silk-antimicrobial materials for 
biomedical applications. Likewise, uranium recognition motifs were 
genetically fused to a partial spider silk protein derived from N. clavapies, and 
then the uranium binding ability of the chimeric silk-uranyl proteins were 
confirmed. This highlights the applicability of such functional silk fusion 
proteins as biosensor capture probe for environmental monitoring applications 
(Krishnaji & Kaplan, 2013).  
Affinity domains are complex and larger in size when compared to the 
peptides or recognition motifs. Therefore, exploring the possibility to 
incorporate affinity domains to partial spider silk might increase the 
applicability of functional silk based materials for other applications, for 
example immunoassays, advanced biosensor and cell culture applications. 
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2 Present investigations 
2.1 Aims of the thesis 
The main aim of the present thesis is to immobilize different affinity domains 
to two variants of partial spider silk proteins (RC and NC) via genetic 
engineering technique. Moreover, to study the functional properties of the silk 
part and added affinity domains in RC/NC silk fusion proteins. Furthermore, 
explore the applicability of such functional RC/NC silk fusion proteins for 
different applications. The specific aims of this thesis have been: 
 
 Paper I: To investigate the possibility to functionalize RC silk 
proteins with different fold-dependent affinity protein domains using 
genetic fusion/linkage followed by functional studies of silk materials 
generated from the RC silk fusion proteins. 
 
 Paper II: To covalently combine two scFvs to RC and NC silk protein 
variants at the gene level and to evaluate the possibility to use scFv-
RC/NC silk fusion proteins as capture probes for generation of 
sensitive immunoassays. 
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2.2 Results and discussion 
2.2.1 Paper I: Recombinant spider silk genetically functionalized with affinity 
domains. 
In paper I, functionalization of RC silk with various affinity domains was 
evaluated. Four different fold dependent affinity domains (Z, C2, ABD and 
M4) were covalently attached to the N-terminus of 4RepCT at the gene level. 
Domains Z (7 kDa) (Nilsson et al., 1987) and ABD (5 kDa) (Kraulis et al., 
1996) are folded into a three helix bundle, and bind to IgG and albumin 
respectively. In contrast, C2 (6 kDa) and M4 (17 kDa) domains contain β/α 
domains (Sauer-Eriksson et al., 1995) and β-sheet barrel (Wu & Wong, 2005) 
respectively, and have affinity towards IgG and biotin, respectively. All four 
recombinant RC silk constructs were successfully produced in the BL21 (DE3) 
strain of E. coli and purified using immobilized metal ion affinity 
chromatography under non-denaturing conditions. It is worth noting that the 
produced RC silk fusion proteins could still be self-assembled to film and fiber 
format despite the relatively large sizes (5-17 kDa) of the affinity domains 
added to the RC silk. Moreover, no additional processing steps are required to 
make fibers and films of RC silk fusion proteins compared to RC silk alone. 
Since target binding ability of the added affinity domains is dependent on their 
secondary structure, Fourier transform infrared spectroscopy (FTIR) analysis 
was performed for films and fibers made from all RC silk fusion proteins. 
FTIR analysis supported maintained β-sheet structure, which is a characteristic 
of 4RepCT, in both film and fiber formats of RC silk fusion proteins. In order 
to evaluate the selective IgG binding ability of Z and C2 domains, a complex 
serum mixture was added to the fibers and films of Z-4RepCT and C2-
4RepCT. Bound IgG was then released and run on the SDS-PAGE, which 
showed a band corresponding to the correct size of IgG (140 kDa), thus 
confirming retained functionality of added Z and C2 domains to selectively 
bind IgG. Likewise, the functionality of added ABD was verified upon 
incubation of complex human plasma to fiber and film of ABD-4RepCT 
followed by the release of bound albumin and gel analysis that confirmed the 
maintained functionality of ABD to selectively bind albumin.  
In order to explore the possibility to create multi-functional silk materials, 
mixed films and mixed fibers were prepared by combining soluble fractions of 
Z-4RepCT and ABD-4RepCT. The ability of mixed films and fibers to 
selectively capture both IgG (by Z-4RepCT) and albumin (by ABD-4RepCT) 
was shown by addition of human plasma to the mixed silk materials followed 
by the release of both bound target molecules as shown by gel electrophoresis, 
thus confirming the concept of multi-functional silk materials.  
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Due to the simplicity and versatility of the biotin-streptavidin system, it has 
gained a significant focus in the field of biotechnology (Diamandis & 
Christopoulos, 1991) and also for being used to link functional groups to 
biomaterials (Wang & Kaplan, 2011; Spieß et al., 2010). Likewise, in the quest 
to link functional groups to RC silk based materials, the possibility to 
covalently link the monomeric streptavidin domain (M4) to 4RepCT has been 
verified in Paper I. To demonstrate the biotin binding ability of the M4 
domain in the M4-4RepCT construct, films of M4-4RepCT were incubated 
with biotinylated DNA molecules. High affinity between monomeric 
streptavidin and biotinylated ligands (Wu & Wong, 2005) resulted in a 
difficulty to release the bound biotinylated ligands. Since release of bound 
biotinylated ligands usually requires harsh elution conditions (Rybak et al., 
2004), a restriction enzyme site was included at the 5’ end of the biotinylated 
DNA molecules to ensure mild release, which could be confirmed by a DNA 
gel. Thus the applicability of M4-4RepCT silk materials for nucleic acid 
hybridization assays is envisioned. Furthermore, functionalization of M4-
4RepCT films with growth factors was evaluated. This concept was confirmed 
by capture of EGF molecules pre-labeled with a chromophoric biotin onto M4-
4RepCT films, followed by measurement of the absorbance signal that come 
from the bound biotinylated EGF molecules.  
In a recent study, a recombinant silk construct named FN-4RepCT was 
shown to enhance the cell supportive ability of spider silk (Widhe et al., 2016). 
Upon combining soluble FN-4RepCT and M4-4RepCT, an advanced silk 
based cell scaffold could possibly be designed for in vitro cell culture studies, 
provided that the basal culture medium is supplemented with biotinylated 
growth factors. Moreover, due to the high affinity between M4 domain and 
biotinylated ligands (Wu & Wong, 2005), long term use of bound biotinylated 
growth factors is envisioned during media change, thus providing an economic 
benefit. 
On the other hand, if release of growth factors is demanded by the cells and 
if it is difficult to biotinylate growth factors, a reversible two-step presentation 
of growth factor via Z-4RepCT materials could instead be employed. The 
feasibility of such two-step approach using Z-4RepCT silk was shown by the 
capture of the growth factor vascular endothelial growth factor (VEGF) using 
anti-VEGF IgG, which was first bound to the Z domain. To visualize the 
indirect binding of VEGF to Z-4RepCT films via anti-VEGF IgG, the VEGF 
was biotinylated and a streptavidin labelled with fluorophore was used for 
detection. 
Since it is challenging to determine the function of biotinylated growth 
factors captured to 4RepCT fusions, a domain with more easily measured 
22 
functionality, the enzyme xylanase, was biotinylated and captured onto M4-
4RepCT films. Activity of bound xylanase was thereafter verified upon 
conversion of the substrate to a product that could be measured at a certain 
wavelength. Higher absorbance signal was observed from M4-4RepCT films 
with biotinylated xylanase than corresponding Z-4RepCT control films, thus 
confirming the maintained activity of the xylanase. This finding highlights the 
possible use of M4-4RepCT silk materials to capture other enzymes which 
have potential applications in the field of biology and medicine (Costa et al., 
2005). 
2.2.2 Paper II: Genetic fusion of single-chain variable fragments to partial 
spider silk improves target detection in micro- and nanoarrays. 
In paper II, one of the attractive features of spider dragline silk proteins, 
namely stickiness (Vollrath, 2000) has been exploited for the development of 
high performing recombinant antibody based immunoassays. In this study, two 
single chain variable fragments (scFvs), αVEGF and αC1q (30 kDa) that bind to 
the serum proteins VEGF (low abundant) and C1q (high abundant) 
respectively, were selected from a human recombinant scFv phage-display 
library (Soderlind et al., 2000). Corresponding genes were then genetically 
attached to either ends of two partial spider silk variants (RC and NC). All of 
the generated RC/NC silk fusion constructs (RC-α and α-RC, 52 kDa, NC-α 
and α-NC, 54 kDa) could be efficiently produced in E. coli and purified using 
immobilized metal ion affinity chromatography (IMAC). Even though a partial 
degradation of target proteins was observed, scFv-silk fusion proteins of 
sufficient quality were obtained. Concentrated fractions of soluble scFv-
RC/NC silk fusion proteins could be processed to silk like fibers. This 
confirmed a retained functionality of RC and NC silk to form silk like fibers 
despite when covalently attached to scFv domain (30 kDa), which is larger in 
size compared to the sizes of both RC (23 kDa) and NC (27 kDa) silk proteins.  
To investigate the target binding affinities of added scFv domains in scFv-
RC silk constructs, a microarray slide carrying microspots of scFv-RC silk 
fusion proteins (RC-αVEGF & αVEGF-RC, RC-αC1q & αC1q-RC) was designed. 
Since silk protein provides a hydrophilic environment and mechanical stability 
to the array spot, this might change the morphology of the array spot and 
thereby affect the outcome of immunoassay. Therefore, mixed spot (soluble 
scFvs and RC added together) and double spot (soluble scFv added onto dried 
RC) formats were formulated to constitute controls of scFvs non-covalently 
attached to RC silk. Incubation of VEGF antigens onto a microarray slide 
revealed VEGF binding to the microspots containing αVEGF, RC-αVEGF and 
αVEGF-RC proteins but almost no binding to the other microspots. Similarly, 
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addition of C1q antigens to the microarray slide showed binding of C1q 
antigens only to the microspots of αC1q, RC- αC1q and αC1q-RC. These 
observations also confirmed that there exists no cross reactivity among 
different scFv-RC silk fusion proteins. Moreover, target detection signal was 
distinctly increased when scFvs were covalently attached to RC silk compared 
to the same added amount of scFvs to the microspots containing only scFv. 
The increase in target binding signal might be due to the high propensity of 
spider silk proteins to self-assemble and adhere to the solid surfaces, thereby 
resulting in well oriented antibody fragments from the fusion protein. Presence 
of well oriented immobilized antibody fragments would enable efficient 
binding to the target molecules, thereby contributing to the success of solid-
phase assays. Likewise, in another study, use of well oriented antibody 
fragments has been shown to improve the target binding (Hu et al., 2013). 
Another reason for improved target detection signal might be that a higher 
proportion of scFvs might have stayed within the array spots during the several 
processing steps involved in the immunoassay when attached to the silk 
protein. On the contrary, very low target detection signal, close to the 
background signal, was obtained from mixed and double spots, thus 
demonstrating the necessity of having scFvs covalently linked to silk when 
used as capture probes in immunoassays. Incubation of non-fractionated serum 
sample onto the microarray slide containing microspots of scFv-RC silk fusion 
proteins confirmed the selective binding between the scFv-silk fusion proteins 
and their respective targets present in the serum. This highlights the ability of 
scFv-RC silk fusion proteins to bind their targets even from a complex sample. 
In the quest for generation of sensitive and high density arrays, possible use 
of scFv-silk fusion proteins as the capture probes was investigated also using 
nanoarrays. Deposition of proteins for nanoarrays can be done by several 
techniques, for example using dip-pen technology (Petersson et al., 2014; 
Wingren & Borrebaeck, 2007). The repetitive region in the RC silk variant has 
a high tendency to fibrillate, which could potentially clog the nozzle if 
deposited using dip-pen technology. To avoid this problem, NTCT (NC), a 
new engineered variant of spider silk was generated, without including the 
repetitive region, and used for nanoarray analysis. Again the previously 
selected scFvs (αVEGF and αC1q) were covalently attached onto either ends, 
resulting in the generation of scFv-NC silk fusion proteins (NC-αVEGF & αVEGF-
NC, NC-αC1q & αC1q-NC). Similar to microarray analysis, upon addition of 
pure antigen samples (VEGF and C1q) onto the nanoarray slides containing 
nanospots of scFv-NC silk fusion proteins, no sign of cross reactivity was 
observed among different scFv-NC silk fusion proteins. Furthermore, 
significantly higher target detection signal was observed by scFvs when 
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covalently attached to NC silk compared to the same added amount of scFvs 
alone. Thus, the results from the nanoarray analysis were in line with 
microarray results. 
In order to rule out unspecific binding of serum components to the silk, C1q 
depleted serum was prepared. Upon addition of C1q depleted serum onto a 
scFv-silk coated nanoarray slide, very low target binding signal was reported 
from NC-αC1q & αC1q-NC, confirming low unspecific binding of serum 
components to scFv-NC silk proteins. To study the array setup using a 
clinically relevant sample, pooled serum from Systemic Lupus Erythematosus 
(SLE) patients was examined. Upon incubation of serum from Systemic Lupus 
Erythematosus (SLE) patients onto the nanoarray slide, a higher target signal 
was reported by αVEGF-NC silk fusion protein compared to incubation with C1q 
depleted serum. This might be due to the high levels of VEGF in serum derived 
from SLE patients (Zhou et al., 2014), which is an hallmark of patients with 
SLE disease compared to low levels of VEGF present in the serum obtained 
from normal patients. The results from the nanoarray analysis confirmed a 
retained functionality of the two scFvs that were attached to NC silk. 
To summarize, in Paper II a procedure to immobilize antibody fragments 
via partial spider silk, which would result in well oriented antibody fragments, 
was demonstrated. Moreover use of scFvs covalently attached to the N-
terminus of partial spider silk could yield stable scFvs within array spots. Thus 
future use of such in vitro targeting agents for sensitive diagnostics is 
envisioned. 
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3 Summary 
Technological advancements have led to the generation of artificial mimics of 
spider silk proteins in amounts sufficient for their use in certain applications. 
Characteristics like biocompatibility and biodegradability exhibited by partial 
spider silk signify their use for cell culture and tissue engineering applications.  
The capability of partial spider silk to adhere to the surfaces can be 
considered for generation of sensitive immunoassays and biosensor related 
applications. 
In paper I, by use of genetic engineering, RC silk was functionalized with 
fold dependent affinity domains (Z, C2, ABD and M4) of different sizes (5-17 
kDa). The resulted RC silk fusion proteins were shown to retain the ability of 
the silk part to self-assemble into silk like fibers. Moreover, the target binding 
ability of the added affinity domains was retained. RC silk functionalized with 
the biotin-binding M4 domain opens up the opportunity to use such functional 
silk materials for several different applications. Ability of M4-4RepCT to bind 
biotinylated growth factors has been validated in paper I. Thus, M4-4RepCT 
silk materials carrying immobilized growth factors could be used as 
extracellular matrix (ECM) analogues for cell culture applications. In many 
cases, attachment of biotin to macromolecules does not alter the biological 
activity of the macromolecules (Diamandis & Christopoulos, 1991). 
Procedures to biotinylate various macromolecules are well established, 
enabling a wide repertoire of available biotinylated macromolecules. Capture 
of such biotinylated macromolecules by M4-4RepCT silk materials could be a 
convenient way to generate various functional silk materials, which could have 
implications for diverse applications.  
In paper II, functionalization of RC and NC silk variants was carried out 
by the covalent attachment of two recombinant antibody fragments (αVEGF and 
αC1q, 30 kDa) to both silk variants at the gene level. Results from this study 
demonstrate the scalability in the size of affinity domains that can be 
covalently attached to the partial spider silk. The functionality of recombinant 
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antibody fragments in the produced scFv-RC/NC silk fusion proteins was 
confirmed by immunoassays. Specific and significantly improved binding of 
the scFv-silk fusion proteins to their respective targets was detected. 
Furthermore, no cross reactivity between different scFv-silk fusion proteins 
was observed. Thus, a novel procedure to immobilize scFvs via partial spider 
silk has been described. The applicability of such improved probe format in 
generation of sensitive immunoassays for efficient disease diagnosis is thus 
envisioned. 
In summary, the ability of partial spider silk to be furnished with different 
functional domains expands the application horizon of such functional partial 
spider silk materials. 
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4 Concluding remarks 
Paper I: Affinity domains that are cloned into recombinant spider silk retain 
their binding specificity when the fusion protein is coated onto a solid surface 
and processed to fiber format. This means that the affinity domain part of the 
fusion protein is folded in such a way that binding properties are maintained, 
and that it is exposed on the surface of the silk well enough to enable efficient 
binding of its target. 
 
Paper II: By genetic linkage of antibody fragments into recombinant silk, it is 
possible to improve sensitivity and signal strength of immunoassays where the 
silk fusion protein is coated onto a surface, as compared to coatings of the 
antibody fragments alone. 
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5 Future studies 
Paper I:  
 Fibers produced from recombinant spider silk were previously 
reported to be well tolerated when implanted in rats (Fredriksson et 
al., 2009). Likewise, in future, fibers generated from M4-4RepCT silk 
could be first used to capture biotinylated antimicrobial drugs for 
example, amikacin (Boyce et al., 1993) followed by their implantation 
to the wounded site. Such type of materials carrying antimicrobial 
drugs could likely be used for local and sustained delivery of drugs to 
alleviate wound healing. 
 Ability of Z-4RepCT silk to capture growth factors in a two-step 
procedure was shown in paper I. Possibility to use Z-4RepCT silk 
with captured growth factors as in vitro cell culture scaffold should be 
evaluated. 
Paper II:  
 The surface properties of the array slide were shown to affect the 
functionality of immobilized biomolecules (Seurynck-Servoss et al., 
2007). Therefore, future study of herein used scFv-silk fusion proteins 
on various array slides made of different materials could provide 
better understanding for their efficient use as capture probes in 
sensitive diagnostic applications. 
 Two recombinant antibody fragments (αVEGF and αC1q) used in paper 
II were selected from a collection of scFvs that contribute to a 
candidate protein signature for diagnosing the autoimmune disease 
SLE (Petersson et al., 2014; Carlsson et al., 2011). In future 
investigations, covalent attachment of other scFvs to the N-terminus of 
NC silk variant could be performed for generation of a sensitive 
nanoarray slide to diagnose SLE disease.  
 Collection of scFv fragments that contribute to the candidate protein 
signature for diagnosis of breast (Olsson et al., 2013) and pancreatic 
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cancers (Wingren et al., 2012) are available. Future use of herein 
described silk based scFv immobilization strategy can possibly result 
in the generation of sensitive array chips for efficient diagnosis of 
prostate and breast cancers. 
 Shelf life study of the array slides containing capture probes is an 
important parameter to consider when designing a chip for disease 
diagnosis. Therefore, long term shelf life studies of the array slides 
containing scFv-silk fusion proteins should be evaluated. 
 The ability of αVEGF-RC silk coating to bind VEGF protein was 
verified in paper II. In future, solutions of the cell adhesion 
promoting FN-silk (Widhe et al., 2016) and VEGF growth factor 
binding αVEGF-RC silk can be mixed and processed to combined silk 
coat. Future study of cellular behavior on cell culture plates containing 
such combined silk coatings would provide valuable information for 
generation of artificial cell culture matrices. 
 Anti-VEGF based therapies has been developed to inhibit the growth 
of new blood vessels, thereby starving tumor cells (Ellis & Hicklin, 
2008). Since αVEGF-RC silk can bind to VEGF, the possibility of 
αVEGF-RC silk to bind VEGF in a way which prevents the angiogenesis 
process could be investigated. Exploring this possibility enables the 
use of αVEGF-RC as a biopharmaceutical for treatment of certain 
cancers. 
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6 Popular scientific summary 
Over several decades spider silk has widely been known for its incredible 
mechanical properties in terms of toughness, strength and elasticity. Spider silk 
is reported to be stronger and tougher than steel and high performance 
synthetic fibers, like Kevlar, by weight. In addition to amazing mechanical 
properties, biocompatibility and biodegradability exhibited by spider silk fibers 
has made spider silk as the subject of research for different biomedical and 
material applications. Certain spiders, like orb weaving spiders, can produce 
several types of silk from various silk glands and the produced silks differ in 
their primary amino acid sequence, physical properties and functions. Out of 
several types of silk produced by spiders, dragline silk, which is used by the 
spiders to capture their prey, is the strongest. Even though researchers have 
succeeded in deciphering the valuable secrets shared by spiders, still there exist 
no possible way to produce spider silk in commercial quantities. The 
cannibalistic behavior exhibited by spiders restricted their farming. A great 
deal of effort by material scientists and biologists had resulted in generation of 
partial spider silk protein in amounts sufficient for certain biomedical 
applications. Furthermore, compared to synthetic high-performance materials, 
artificial spider silk is produced using renewable resources. If produced at large 
scale, spider silk might has the ability to be used as an alternative to stainless 
steel, thus contribute to the generation of ecological materials. 
Mainly for economic reasons, E. coli bacteria, has often been chosen for the 
production of partial spider silk. Since large gene size of full length spider silk 
cannot be handled by bacteria, pieces of full length spider silk gene are 
selected and were transferred to bacteria thus resulted in the production of 
partial spider silk proteins. 
The applicability of produced partial spider silk proteins for various 
applications within the field of medicine and biotechnology can be increased 
by a process called functionalization, in which different biological properties 
are incorporated to partial spider silk. Likewise, this thesis is focused on 
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functionalization of two partial spider silks (4RepCT (RC) and NTCT (NC)) 
with various affinity domains using genetic engineering. RC and NC partial 
spider silks are derived from the dragline silk of the spider E. australis. In 
paper I and II, we have shown that different affinity properties can be 
incorporated to RC and NC partial spider silks by covalently combining 
various affinity proteins to partial spider silk proteins using genetic engineering 
techniques, thus resulting in RC and NC silk fusion proteins. Both in paper I 
and II, we observed that the ability of the silk part in RC and NC silk fusion 
proteins to spontaneously form fibers is still maintained despite the fusion of 
different protein domains. Moreover, the target binding properties of the added 
protein domains are maintained in the RC and NC silk fusion proteins. In paper 
I, we could show the ability of M4-4RepCT and Z-4RepCT silk materials to 
bind biomolecules in two different ways, which are essential for human cell 
culture. We also showed the ability of M4-4RepCT to present an active 
enzyme in paper I. Thus use of such silk materials has been contemplated for 
their use in tissue engineering applications. In paper II, we have shown that the 
ability of anti-VEGF and anti-C1q proteins to recognize their target molecules 
has significantly been improved when attached to NC silk. This hints the future 
of NC silk fusion proteins for applications where improvement of target 
recognition is required. 
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7 Populärvetenskaplig sammanfattning 
Under flera decennier har spindeltråd varit allmänt känd för sina otroliga 
mekaniska egenskaper i termer av bland annat styrka och elasticitet. 
Spindeltråd rapporteras vara starkare än stål och högpresterande syntetfibrer, 
såsom Kevlar, per vikt. Förutom fantastiska mekaniska egenskaper har även 
biokompatibilitet och bionedbrytbarhet hos spindeltrådsfibrer gjort spindeltråd 
intressant för olika biomedicin- och materialtillämpningar. Vissa spindlar kan 
producera flera olika typer av silke från olika silkeskörtlar och de framställda 
silkena skiljer sig åt i sin primära aminosyrasekvens, fysikaliska egenskaper 
och funktioner. Av de olika typerna av silke som produceras av spindlar är 
”dragline-silke”, som används av spindlar för att fånga sitt byte, den starkaste. 
Även om forskare har lyckats dechiffrera värdefulla hemligheter om spindlar 
och dess tråd finns det fortfarande inget sätt att framställa spindeltråd i 
kommersiella kvantiteter. Det kannibalistiska beteende som spindlar uppvisar 
har begränsat möjligheten att föda upp spindlar i större skala. Gemensamma 
arbetsinsatser av materialforskare och biologer har dock resulterat i generering 
av partiella silkesproteiner i mängder som är tillräckliga för vissa 
biomedicinska tillämpningar. Dessutom är artificiell spindeltråd producerad 
med hjälp av förnybara resurser jämfört med syntetiska material. När de 
produceras i stor skala skulle spindelsilke kanske ha förmåga att kunna 
användas som ett alternativ till rostfritt stål i vissa applikationer och på så sätt 
bidra till genereringen av ekologiska material. 
Av främst ekonomiska skäl har ofta E. coli-bakterier använts för 
framställning av partiellt spindelsilke. Eftersom den stora genstorleken av 
naturliga spindeltrådsproteiner inte kan hanteras av bakterier har istället kortare 
bitar av fullängdsgenen valts ut och överförts till bakterier för att på så sätt 
producera partiella spindelsilkesproteiner istället. 
Användbarheten av de producerade partiella silkesproteinerna för olika 
tillämpningar inom områden som medicin och bioteknik kan ökas med en 
process som kallas funktionalisering, där olika biologiska egenskaper 
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inkorporeras i det partiella spindelsilket. Denna avhandling fokuserar på 
funktionalisering av två partiella spindelsilkesproteiner (4RepCT (RC) och 
NTCT (NC)) med olika affinitetsdomäner med hjälp av genteknik. Partiellt 
RC- och NC-silke härstammar från dragline-silke från spindeln E. australis. I 
artikel I och II har vi visat att olika affinitetsegenskaper kan tillföras RC- och 
NC-silke genom att kovalent kombinera olika affinitetsproteiner med de 
partiella silkesproteinerna genom att använda genteknik, vilket resulterar i RC- 
och NC-silkesfusionsproteiner. Både i artikel I och II observerade vi att 
förmågan hos silkesdelen i RC- och NC-fusionsproteinerna att spontant bilda 
fibrer fortfarande upprätthålls trots kovalent koppling till de olika 
affinitetsdomänerna. Dessutom bibehölls de målmolekylbindande 
egenskaperna hos de tillsatta affinitetsdomänerna i RC- och NC-
fusionsproteinerna. I artikel I kunde vi demonstrera förmågan hos M4-
4RepCT- och Z-4RepCT-silkesmaterial att binda biomolekyler på två olika 
sätt, båda väsentliga för till exempel odling av humana celler. Vi visade också 
på förmågan hos M4-4RepCT att presentera ett aktivt enzym i artikel I. Vi tror 
att sådana här funktionaliserade silkesmaterial skulle kunna användas för 
avancerade cellodlingstillämpningar, såsom i fältet ”tissue engineering”. I 
artikel II visade vi att förmågan hos anti-VEGF- och anti-C1q-proteiner för att 
känna igen sina målmolekyler väsentligt förbättrades när de var kovalent 
kopplade till NC-silke. Detta antyder att NC-silkesfusionsproteiner i framtiden 
kan användas för applikationer där det krävs en förbättring av 
målmolekyligenkänning. 
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